Medical Science Liaison
Orca BioFull Time
Junior (1 to 2 years)
Candidates should possess an advanced degree in health sciences such as a PharmD, MD, or PhD in a medically related field, with at least two years of experience in hematologic malignancy or cell therapy. A Master's degree in health sciences with extensive clinical or medical affairs experience in the relevant therapeutic area is also considered. Two or more years of experience as a Medical Science Liaison (MSL) or in Medical Affairs within the relevant therapeutic area is required. Familiarity with healthcare systems and access environments, strong partnering and influencing skills, excellent communication and presentation abilities, personal integrity, and an agile, adaptable, results-oriented mindset are essential. The candidate must reside within the territory.
The Medical Science Liaison will establish and maintain relationships with healthcare professionals (HCPs) in the hematology field through in-person and virtual interactions. They will develop and execute territory plans aligned with Medical Affairs strategies, interacting with thought leaders, disease experts, and academic centers. Responsibilities include compliantly supporting field-based teams, delivering approved medical and scientific education on disease states and Arcellx products, and gathering insights from external stakeholders to inform medical strategies and clinical programs. The MSL will also represent Arcellx at conferences, partner with clinical operations for trial execution, and travel approximately 50-70% domestically.
Develops immunotherapies for cell therapy
Arcellx develops immunotherapies aimed at improving cell therapy for serious diseases. Their products focus on advanced techniques that enhance the effectiveness of treatments. The company collaborates with healthcare providers and research institutions to bring these therapies to patients. Unlike many competitors, Arcellx emphasizes proprietary products and partnerships to drive their research and development efforts. The goal is to meet unmet medical needs by providing safe and effective treatment options through their innovative approach to cell therapy.